DEVELOPING NEXT-GENERATION
TARGETED DRUG DELIVERY TECHNOLOGY
Our lab is dedicated to developing targeted drug delivery technology for the treatment of cancer and autoimmune disorders. Located on the beautiful campus of Binghamton University in upstate New York, we are particularly focused on the design of next-generation antibody-drug-conjugates (ADCs) for the treatment of immunological disorders and cancer.